Deterioration in Counterparty Performance Due to Changes in Health Administration
First written in FY2024. 5 of 7 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 7 of 16 companies on the "Worse" side.
7 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The basic policy for the FY2026 revision of medical-service fees identifies responding to changes in the operating environment, including higher prices and wages and labor shortages, as a key issue. Although this is expected to be a somewhat positive factor for improving medical institutions' earnings, it has not yet resulted in a fundamental improvement in the operating environment.」
The Company recognizes that the difficult operating environment for counterparties, including higher prices and wages and labor shortages, is continuing under regulated pricing systems such as medical and nursing-care reimbursement. - FY2026-H1RestatedAnnual report
「The basic policy for the FY2026 revision of medical-service fees identifies responding to changes in the operating environment, including higher prices and wages and labor shortages, as a key issue. Although this is expected to be a somewhat positive factor for improving medical institutions' earnings, it has not yet resulted in a fundamental improvement in the operating environment.」
The Company recognizes that the operating environment for medical institutions remains challenging under regulated pricing systems such as medical and nursing-care reimbursement. It expects some improvement from the FY2026 revision of medical-service fees but states that there has been no significant change in the existing risks. - FY2025-H1RestatedAnnual report
「As a result, it is difficult to promptly reflect sharp increases in prices and wages in reimbursement rates, and the operating environment is becoming increasingly challenging.」
The Company describes the existing external-environment risk associated with regulated pricing and medical and nursing-care reimbursement, including the difficulty of passing higher prices and wages through to reimbursement rates. It also states that there have been no significant changes to business risks. - FY2024First statedAnnual report
「Health administration is periodically reviewed, primarily with respect to reimbursement systems, in order to restrain the rising proportion of social security costs in the national budget. Depending on the content of these revisions, the management results of many of our Group's counterparties could be materially affected.」
The Company identifies the risk that revisions to systems such as medical and nursing-care reimbursement could worsen counterparty performance and affect its financial position and results of operations.